IDEAYA Biosciences (IDYA) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart

IDEAYA Biosciences Revenue Highlights

Latest Revenue (Y)

$218.71M

Latest Revenue (Q)

$207.83M

Main Segment (Y)

Research and Development Services

IDEAYA Biosciences Revenue by Period

IDEAYA Biosciences Revenue by Year

Date	Revenue	Change
2025-12-31	$218.71M	3024.43%
2024-12-31	$7.00M	-70.07%
2023-12-31	$23.39M	-54.08%
2022-12-31	$50.93M	82.28%
2021-12-31	$27.94M	43.01%
2020-12-31	$19.54M	100.00%
2019-12-31	-	100.00%
2018-12-31	-	100.00%
2017-12-31	-	-

IDEAYA Biosciences generated $218.71M in revenue during NA 2025, up 3024.43% compared to the previous quarter, and up 1119.41% compared to the same period a year ago.

IDEAYA Biosciences Revenue by Quarter

Date	Revenue	Change
2025-09-30	$207.83M	100.00%
2025-06-30	-	100.00%
2025-03-31	-	-100.00%
2024-12-31	$7.00M	100.00%
2024-09-30	-	100.00%
2024-06-30	-	100.00%
2024-03-31	-	-100.00%
2023-12-31	$3.92M	-51.19%
2023-09-30	$8.04M	126.81%
2023-06-30	$3.54M	-55.03%
2023-03-31	$7.88M	95.92%
2022-12-31	$4.02M	-86.46%
2022-09-30	$29.70M	407.59%
2022-06-30	$5.85M	-48.49%
2022-03-31	$11.36M	283.36%
2021-12-31	$2.96M	-66.99%
2021-09-30	$8.98M	2.51%
2021-06-30	$8.76M	20.82%
2021-03-31	$7.25M	-31.44%
2020-12-31	$10.57M	17.89%
2020-09-30	$8.97M	100.00%
2020-06-30	-	100.00%
2020-03-31	-	100.00%
2019-12-31	-	100.00%
2019-09-30	-	100.00%
2019-06-30	-	100.00%
2019-03-31	-	100.00%
2018-12-31	-	100.00%
2018-09-30	-	100.00%
2018-06-30	-	100.00%
2018-03-31	-	-

IDEAYA Biosciences generated $207.83M in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

IDEAYA Biosciences Revenue Breakdown

IDEAYA Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 22	Dec 21	Dec 20
Research and Development Services	$161.85M	-	-	-
Methionine Adenosyl Transferase2 A Program Supply	-	$2.40M	$2.41M	$2.35M
Polymerase Theta Program Research And Development Service	-	-	$13.75M	$25.78M
Werner Helicase Program Research And Development Service	-	-	$20.83M	$27.79M
Methionine Adenosyl Transferase2 A Program Research And Development	-	-	$9.49M	$16.14M
The Option	-	-	$17.68M	$17.23M

IDEAYA Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 25: Research and Development Services (100.00%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21
Research and Development Services	$18.72M	$143.13M	-	-	-	-	-	-	-	-	-
Werner Helicase Program Research And Development Service	-	-	$1.44M	$2.82M	$6.25M	$16.06M	$18.16M	$19.09M	$22.39M	$23.78M	$25.69M
Polymerase Theta Program Research And Development Service	-	-	-	-	-	$2.12M	$10.00M	$11.27M	$12.76M	$17.32M	$22.39M
Methionine Adenosyl Transferase 2 A Option Member	-	-	-	-	-	-	$17.47M	$17.49M	-	-	-
Methionine Adenosyl Transferase2 A Program Research And Development	-	-	-	-	-	-	-	$3.78M	$10.29M	$13.02M	$14.77M
The Option	-	-	-	-	-	-	-	-	$17.37M	$17.32M	$17.31M
Methionine Adenosyl Transferase2 A Program Supply	-	-	-	-	-	-	-	-	$2.37M	$2.36M	$2.36M

IDEAYA Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Research and Development Services (100.00%).

IDEAYA Biosciences Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
KNSA	Kiniksa Pharmaceuticals	$677.56M	$180.85M
FOLD	Amicus Therapeutics	$634.21M	$169.06M
ZLAB	Zai Lab	$460.16M	$116.09M
LEGN	Legend Biotech	$285.14M	$93.99M
ADPT	Adaptive Bio	$276.98M	$58.88M
IDYA	IDEAYA Biosciences	$218.71M	$207.83M
CDTX	Cidara Therapeutics	$1.27M	-
COGT	Cogent Biosciences	-	-
MLYS	Mineralys Therapeutics	-	-
SRRK	Scholar Rock	-	-
BEAM	Beam Therapeutics	-	-

IDYA Revenue FAQ

What is IDEAYA Biosciences’s yearly revenue?

IDEAYA Biosciences's yearly revenue for 2025 was $218.71M, representing an increase of 3024.43% compared to 2024. The company's yearly revenue for 2024 was $7M, representing a decrease of -70.07% compared to 2023. IDYA's yearly revenue for 2023 was $23.38M, representing a decrease of -54.08% compared to 2022.

What is IDEAYA Biosciences’s quarterly revenue?

IDEAYA Biosciences's quarterly revenue for Q3 2025 was $207.83M, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). IDYA's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is IDEAYA Biosciences’s revenue growth rate?

IDEAYA Biosciences's revenue growth rate for the last 3 years (2023-2025) was 835.26%, and for the last 5 years (2021-2025) was 682.76%.

What are IDEAYA Biosciences’s revenue streams?

IDEAYA Biosciences's revenue streams in c 25 are Research and Development Services

What is IDEAYA Biosciences’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of IDEAYA Biosciences was Research and Development Services. This segment made a revenue of $161.85M, representing 100.00% of the company's total revenue.